Search

everythinglearnresearchcommunity

for

Search:↓

Managing side effects of endocrine therapy is crucial to improve adherence and survival in breast cancer patients.

Using three different drugs together may better treat eye diseases like glaucoma and macular degeneration.

Mogamulizumab, a skin cancer drug, may cause hair loss similar to alopecia areata.

Mesotherapy might improve hair growth, but more research is needed to confirm its safety and effectiveness.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Baricitinib is a promising treatment for severe alopecia areata with minimal side effects.

Hair is important for protection, social interaction, and temperature control, and is made of a growth cycle-influenced follicle and a complex shaft.

Platelet-Rich Plasma therapy significantly increases hair density in people with Androgenic Alopecia, and works better with more treatments per month and in younger patients.

A young woman with kidney cancer experienced rare hair loss from a cancer drug and unusual cancer spread, suggesting early drug treatment might reduce spread and prolong survival.

Tofacitinib may effectively treat hair loss and improve symptoms in autoimmune conditions like alopecia areata and Sjögren's syndrome, but long-term treatment might be necessary.

New treatments like nanotechnology show promise in improving skin cancer therapy.

Hidradenitis Suppurativa has genetic links, with certain gene mutations more common in patients and a third of cases having a family history.

Cushing's syndrome can cause serious health problems, and early treatment is crucial, but some issues may remain after treatment.

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Pregnancy can cause skin darkening, varicose veins, more sweating, hair growth, hair loss after birth, nail changes, and gum inflammation.

Finasteride negatively affects fish reproduction and gonadal development.

Surface-modified nanostructured lipid carriers can improve hair growth treatments.

New treatments targeting immune pathways show promise for severe hair loss but need more research for safety and effectiveness.

Oral tofacitinib significantly improves lichen planopilaris symptoms without adverse effects.

Baricitinib helps treat several diseases, including COVID-19, but has side effects and needs careful monitoring.

Hair loss linked to higher heart disease risk in both men and women.

Acne inversa is an epithelial-driven disease where inflammation is caused by cyst rupture, and treatments should focus on preventing tendril growth for better results.

Wnt activation shows promise for regenerative medicine but requires selective targeting to minimize risks like cancer.

Adult female acne treatment should be personalized, considering individual preferences and pregnancy, using various topical and oral medications while managing side effects and resistance.

Teriflunomide is an effective and generally safe oral treatment for relapsing MS, reducing relapses and slowing disability progression.

People with alopecia areata often have higher rates of allergies and autoimmune diseases.

Dermal papilla cells are key for hair growth and color, influencing hair type and size, and their interaction with stem cells could help treat hair loss and color disorders.

Women with telogen effluvium have lower levels of iron, folate, and vitamin B12.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.